omatic lower extremity
atherosclerosis.81 The American Heart Association practice
guidelines for lower extremity ischemia rated this treatment

10S Conte and Pomposelli et al

recommendation class I-A.43 In the 6452 patients with PAD
in the Clopidogrel vs Aspirin In Patients At Risk of Ischaemic
Events trial, clopidogrel reduced the myocardial infarction,
stroke, or vascular death rate